ロード中...
A pilot study of temsirolimus and body composition
PURPOSE: Body weight and composition play a role in cancer etiology, prognosis, and treatment response. Therefore, we analyzed the weight, body composition changes, and outcome in patients treated with temsirolimus, an mTor inhibitor that has weight loss as one of its side effects. PATIENTS AND METH...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Berlin Heidelberg
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3830004/ https://ncbi.nlm.nih.gov/pubmed/23893509 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13539-013-0113-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|